Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
JCO Precis Oncol. 2024 Mar;8:e2300446. doi: 10.1200/PO.23.00446.
Homologous recombination proficiency in patients with breast cancer despite germline PALB2/RAD51C pathogenic variants.
乳腺癌患者尽管存在胚系 PALB2/RAD51C 致病性变异,仍具有同源重组修复能力。